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Key points
 Skeletal muscle energy requirements increase at birth but little is known regarding the
development of mitochondria that provide most of the cellular energy as ATP.
 Thyroid hormones are known regulators of adult metabolism and are important in driving
several aspects of fetal development, including muscle fibre differentiation.
 Mitochondrial density and the abundance of mitochondrial membrane proteins in skeletal
muscle increased during late gestation. However, mitochondrial functional capacity, measured
as oxygen consumption rate, increased primarily after birth.
 Fetal hypothyroidism resulted in significant reductions in mitochondrial function and density
in skeletal muscle before birth.
 Mitochondrial function matures towards birth and is dependent on the presence of thyroid
hormones, with potential implications for the health of pre-term and hypothyroid infants.
Abstract Birth is a significant metabolic challenge with exposure to a pro-oxidant environment
and the increased energy demands for neonatal survival. This study investigated the development
of mitochondrial density and activity in ovine biceps femoris skeletal muscle during the perinatal
periodandexamined the role of thyroidhormones in theseprocesses.Muscle capacity foroxidative
phosphorylation increased primarily after birth but was accompanied by prepartum increases in
mitochondrial density and the abundance of electron transfer system (ETS) complexes I–IV and
ATP-synthase as well as by neonatal upregulation of uncoupling proteins. This temporal disparity
between prepartum maturation and neonatal upregulation of mitochondrial oxidative capacity
may protect against oxidative stress associated with birth while ensuring energy availability to
the neonate. Fetal thyroid hormone deficiency reduced oxidative phosphorylation and prevented
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the prepartum upregulation of mitochondrial density and ETS proteins in fetal skeletal muscle.
Overall, the data show that mitochondrial function matures over the perinatal period and is
dependent on thyroid hormones, with potential consequences for neonatal viability and adult
metabolic health.
(Received 24 October 2019; accepted after revision 5 February 2020; first published online 22 February 2020)
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Introduction
Birth is a significant metabolic challenge to the neonate.
It must maintain its internal environment for the first
time and activate many vital processes that have little or
no function in utero, including pulmonary respiration,
enteral nutrition, gluconeogenesis and thermoregulation
(Fowden et al. 1998). Consequently, neonatal energy
demands rise rapidly after birth as organs and tissues
assume these new roles. The energy needed is provided
as ATP, produced primarily by oxidative phosphorylation
(OXPHOS) in the mitochondria, which requires and
accounts for the significant increase in the rate of oxygen
consumption after birth (Klein et al. 1983). This, together
with the fluctuations in arterial partial pressure of oxygen
( PaO2 ) during labour and the rapid rise in O2 exposure at
birth, increases the risk of excessive mitochondrial super-
oxide production and oxidative damage to the neonatal
tissues (Rogers et al. 1998). Preparations for the neonatal
metabolic challenges begin before birth in several of the
key tissues essential for neonatal survival, but little is
known regarding the normal prepartum maturation of
mitochondrial function in any fetal tissue.
In adults, mitochondria are highly dynamic organelles
and respond to changes in cellular energy demands by
biogenesis/mitophagy, by fusion/fission, andbyalterations
in the abundance of the electron transfer system (ETS)
and other proteins regulating ATP and superoxide
production (Nunnari & Suomalainen, 2012; Schrepfer
& Scorrano, 2016). With substrates provided via the
tricarboxylic acid cycle and other intermediary pathways,
ATP is synthesised from ADP by ATP synthase using the
protongradient across the innermitochondrialmembrane
(IMM) generated by the redox reactions at the ETS protein
complexes (Nunnari & Suomalainen, 2012; Schrepfer &
Scorrano, 2016). The electrons derived from the reducing
equivalents pass along the ETS to produce water using
O2 but they can also be diverted from the ETS to
form superoxide, particularly when the proton gradient
is high or there are abnormalities in the O2 or sub-
strate supply (Aledo, 2014). In addition, mitochondrial
respiratory function is regulated, in part, by uncoupling
proteins (UCPs), which dissipate the proton gradient,
thereby decreasing superoxide production but also
OXPHOS efficiency (Adjeitey et al. 2013). Furthermore,
ATP production depends on ADP availability which is
controlled by the IMM transporter adenine nucleotide
translocase (ANT) using the proton gradient (Brand et al.
2005). Relatively little is known about the ontogenic
changes in any of these mitochondrial proteins during the
perinatal period, although alterations in UCP expression
have been observed during late gestation in the fetal lung
and adipose tissue (Mostyn et al. 2003; Gnanalingham
et al. 2005).
With the onset of pulmonary respiration, locomotion
and shivering thermogenesis at birth, skeletal muscle
makes a significant contribution to the increased energy
demand and total rate of O2 consumption seen neonatally,
particularly in precocial species such as sheep which
are mobile shortly after birth. Skeletal muscles generally
consist of a mixture of fibre types which are subdivided
into two main types: slow twitch, oxidative type I fibres
with abundant mitochondria, and fast twitch type II
fibres with fewer mitochondria and which carry out
oxidative/glycolytic (type IIa) or predominantly glycolytic
metabolism (type IIx; Yates et al. 2016). These fibre types
can be identified by their expression of the different myo-
sin heavy chain (MHC) isoforms, MHCI, MHCIIa and
MHCIIx (Yates et al. 2016). Themajority of skeletalmuscle
fibres are formed during mid-gestation with both slow
and fast twitch fibres present by late gestation in pre-
cocial species (Javen et al. 1996).However, the specificfibre
composition of individual muscles reflects their function,
neuronal stimulation and the environmental conditions
during intrauterine development (Gambke et al. 1983).
Manyof the prepartummaturational processes essential
for neonatal survival depend on hormonal changes in the
fetus in the period immediately before birth. In particular,
the increases in fetal cortisol and tri-iodothyronine
(T3) concentrations towards term are important for
the successful transition to extrauterine life in several
species, including sheep and humans (Fowden et al.
1998; Forhead & Fowden, 2014). Thyroid hormones also
affect metabolic rate and mitochondrial function through
actions on mitochondrial biogenesis as well as UCP and
ANT expression in adult tissue, including skeletal muscle
(Dummler et al. 1996; Barbe et al. 2001; Wulf et al.
2008; Lombardi et al. 2015). In addition, in species that
are immature at birth (e.g.rodents), thyroid hormones
are known to influence the maturational development
of muscle morphology and bioenergetics in the period
after birth (Lombardi et al. 2015; Bloise et al. 2018).
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However, much less is known about the metabolic role of
thyroid hormones in utero, although the whole body rate
of O2 consumption is positively correlated to thyroxine
(T4) concentrations in fetal sheep during late gestation
(Fowden& Silver, 1995). Previous studies have also shown
that thyroid hormones can affect the fibre phenotype
of fetal ovine muscles and the rate of O2 consumption
by specific porcine muscles around the time of birth
(Finkelstein et al. 1991; Herpin et al. 1996). However,
little is known about the role of thyroid hormones in the
development of skeletal muscle mitochondria during the
perinatal period when T3 concentrations are rising most
rapidly in preparation for extrauterine life. The current
study therefore examined the ontogeny of mitochondrial
function in ovine skeletal muscle during late gestation
and early neonatal life and tested the hypothesis that any
ontogenic changes would be dependent on fetal thyroid
hormone availability.
Materials and methods
All animal procedures were regulated by project and
personal licences under the UK Animals (Scientific
Procedures) Act 1986 Amendment Regulations 2012
after ethical review by the University of Cambridge
Animal Welfare and Ethical Review Body (UBS:
AWERB.0902.2018.1A). All investigators understood and
worked by the ethical principles and standards discussed
by Grundy (2015).
Experimental procedures
Eighteen Welsh Mountain ewes bearing twins and six
newborn twin lambs were used in this study. Ewes
bought from commercial sheep sales were transported to
University of Cambridge designated premises according
to the UK’s Live transport: welfare regulations 2012.
They were mated and maintained on site both before
and during the experimental procedures. All pregnant
and lactating ewes were group housed and had free
access to hay and water. At 102–105 days of gestational
age after fasting for 18–24 h (dGA; term 145 dGA),
12 of the pregnant ewes underwent surgery in which
one twin fetus was thyroidectomised (TX) while the
other was sham-operated under isofluorane anaesthesia
(1.5–2% in 5:1 O2/N2O mixture) as described previously
(Forhead et al. 2002). A pulse oximeter and capnograph
were used to monitor maternal heart rate, PO2 and
PCO2 throughout surgery with the oxygen flow rate
and percentage isofluorane adjusted accordingly. Ewes
received analgesia (1 mg kg−1 carprofen, S.C.) and anti-
biotics (oxytetracycline, 20 mg kg−1 I.M. and penicillin,
15 mg kg−1 I.M. to mother and I.A. to fetus) on the day
of surgery with maternal penicillin treatment continuing
for two further days. These ewes and their fetuses were
killed for tissue collection at either 126–129 dGA (n = 6
ewes) or 140–145 dGA(n = 6 ewes). The order of delivery
of the TX or sham-operated fetus was randomised, as
the uterine horn containing each fetus was known from
surgery. Tissue was also collected after euthanasia from
the fetuses of the remaining six unoperated twin pregnant
ewes at 102–105 dGA and from six unoperated newborn
twin lambs at 1–2 days of postnatal age. Only one of
each pair of unoperated twins was selected randomly for
further study to ensure a mixture of sexes and order of
delivery, where relevant. The male to female ratios in the
groups were as follows: 104 dGA 2:4; 127 dGA sham 3:3;
127 dGA TX 3:3; 143 dGA sham 2:4; 143 dGA TX 2:4;
newborns 3:3. All ewes, fetuses and newborn lambs were
killed via an overdose of anaesthetic (200mg kg−1 sodium
pentobarbitone, I.V.). Blood samples were taken from the
umbilical artery of the fetuses or from jugular vein of
the lambs and centrifuged in heparin-coated tubes before
plasma storage at −20°C for future hormone analysis.
After euthanasia, the fetus or lamb was weighed
and biometric measurements were taken including
crown–rump length (CRL) and limb lengths. The biceps
femoris (BF) was immediately collected from the left leg
and weighed. A portion from the centre of the muscle
(Kohn & Myburgh, 2007) was collected into ice cold
biopsy preservation medium (BIOPS; pH 7.1 solution
containing 10 mM Ca-EGTA buffer, 0.1 μM free Ca2+,
1 mM free Mg2+, 20 mM imidazole, 20 mM taurine, 50 mM
K-MES, 0.5 mM dithiothreitol, 6.56 mM MgCl2, 5.77 mM
ATP and 15 mM phosphocreatine; Pesta & Gnaiger, 2012)
for respirometry. A second portion of the muscle was
fix-frozen for immunohistochemistry by immersion in
PBS before transferring to pre-cooled isopentane. The
remaining tissue was snap-frozen in liquid nitrogen and
the fix-frozen tissue was stored at −80°C until required.
Biochemical analyses
Hormone assays. Cortisol concentrations weremeasured
using a commercial human enzyme-linked immunoassay
(IBL International, Hamburg, Germany), validated for
use with sheep plasma (Vaughan et al. 2016). Inter-assay
variation was 4.80% and intra-assay variation was 2.65%.
The limit of detection of the assay was 5.2 ng ml−1.
Total plasma T3 and T4 concentrations were measured
using radioimmunoassays (MP Biomedical, Santa Ana,
CA, USA) validated for use with sheep plasma (Fowden &
Silver, 1995). For T3, inter-assay variation was 7.59% and
intra-assay variation was 2.28%. The limit of detection of
the assay was 0.14 ng ml−1. For T4, inter-assay variation
was 4.57% and intra-assay variation was 3.04%. The limit
of detection of the assay was 11.3 ng ml−1.
Skeletal muscle composition. Sections of muscle were
weighed, freeze-dried for 24 h and re-weighed in order
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to calculate percentage water content. Total protein
was extracted from frozen fetal skeletal muscle samples
(55 mg ± 10%), and concentration was measured using a
bicinchoninic acid assay. Protein content was expressed as
mg protein per gram tissue (wet weight) or as mg protein
per mg dry weight depending on the measurement to be
normalised.
Respirometry. Respirometry was carried out as described
previously for skeletal muscle samples (Kuznetsov et al.
2008; Pesta & Gnaiger, 2012). Briefly, muscle samples
in ice cold BIOPS were dissected into 2–3 mg pieces,
fibres were teased apart and plasma membranes were
permeabilised (100 μg saponin ml–1 BIOPS; 20 min).
Oxygen consumption of muscle fibre bundles was
measured in an isotonic sucrose-based respiration
medium (MiR05; pH 7.1 solution containing 20 mM
HEPES, 0.46 mM EGTA, 2.1 mM free Mg2+, 90 mM
K+, 10 mM Pi, 20 mM taurine, 110 mM sucrose,
60 mM lactobionate and 1 g l−1 BSA; Pesta & Gnaiger,
2012) which was developed to optimise mitochondrial
respiration in ex vivo preparations at 37°C (Gnaiger
et al. 2000). Oxygen consumption was measured using
Clark-type oxygen electrodes (Strathkelvin Instruments,
Glasgow, UK). Mitochondrial respiratory studies were all
carried out at 37°C in line with standard practice for
mammalian respirometry measurements. The use of a
single temperature allowed us tomake direct comparisons
of mitochondrial respiratory capacity across all groups,
which would not otherwise have been possible owing to
effects of temperature on oxygen electrode behaviour and
oxygen saturation in the respiratory medium.
After a baseline period, substrates were introduced
into the chambers according to three different protocols.
First, 2 mM malate plus 10 mM glutamate were added to
saturate electron entry via complex I of the ETS, initially
without ADP (leak state) and then with 10 mM ADP
(OXPHOS state), before 10 mM succinate was added to
additionally support electron entry via complex II and
thereby saturate electron entry to the electron transport
chain. In the two subsequent assays, more physiological
substrates were provided to probe substrate-led pathways.
Accordingly, in the second assay, 2 mM malate plus 5 mM
pyruvate ± ADP, was provided to probe the capacity for
the oxidation of pyruvate, which is derived from glucose
in vivo via glycolysis andmetabolised in the mitochondria
by pyruvate dehydrogenase, supporting electron trans-
port through the generation of NADH. Finally, in the
third assay, 2 mM malate plus 40 μM palmitoyl carnitine
(PC) ± 10 mM ADP were added to saturate β-oxidation
and indicate the capacity for mitochondrial fatty acid
oxidation. All three protocols concluded with the addition
of 10 μM cytochrome c to check the integrity of the
outer mitochondrial membrane. Results were excluded if
there was an increase in O2 consumption of 15% or more
upon cytochrome c addition, or if the rate of O2 uptake
over the baseline period, before substrates were added,
exceeded 0.001 μmol O2 min–1 indicating insufficient
plasma membrane permeabilisation (Kuznetsov et al.
2008). The samples were dried at 80°C for 48 h and
weighed to normalise the respiration rates to tissue dry
weight. Results are given as O2 consumption mg–1 dry
weight.
Enzyme assays. Citrate synthase (CS) activity of
30 μg homogenised BF protein was measured
spectrophotometrically at 37°C. The assay buffer (pH
8) contained 0.1 mM 5,5′-dithio-bis(2-nitrobenzoic acid)
(DTNB), 1 mM oxaloacetate and 0.3 mM acetyl-CoA. The
maximal rate of change of absorbance at 412 nm [rate
of 5-thio-2-nitrobenzoic acid (TNB) production] over a
3 min period was used to determine CS activity, expressed
per mg protein. To directly normalise respirometry data
to CS activity, CS activity was initially converted to
activity mg–1 dry weight using water and protein content
values.
β-Hydroxyacyl-CoA dehydrogenase (HOAD) activity
of 20 μg homogenised muscle protein was measured
spectrophotometrically at 37°C. The assay buffer (pH 7.4)
contained 0.15 mM NADH and 0.1 mM acetoacetyl-CoA.
The rate of change of 340 nm absorbance (oxidation of
NADH to NAD+) over the following 3 min period was
used to determine HOAD activity.
Western blotting. Total protein was extracted from
frozen BF samples (55 mg ± 10%), diluted to 2.5 μg μl−1
in 8% SDS solution and electrophoresed on a 12% poly-
acrylamide gel. Protein was transferred to nitrocellulose
membrane and stained using Ponceau-S for normalisation
of protein loading. Membranes were probed with
primary antibodies to ETS complexes (OXPHOS antibody
cocktail; Life Technologies, Carlsbad, CA, USA; 458099;
1:1000; RRID: AB 2533835), followed by HRP-linked
secondary antibody (GE Healthcare, Amersham, UK;
NIF82; 1:5000). Protein bands were visualised using
enhanced chemiluminescence for quantification using
ImageJ (http://rsb.info.nih.gov/ij/).
Gene expression analyses. RNA was extracted from
frozen skeletal muscle using TRIzol (Thermo Fisher
Scientific, Invitrogen, Waltham, MA, USA) and
chloroform and the aqueous phase was separated and
used in an RNeasy Plus kit (Qiagen, Manchester, UK).
The concentration of the eluted RNA was measured
using a Nanodrop ND-1000 spectrophotometer, diluted
to 50 ng μl−1 and reverse transcribed to cDNA (High
Capacity cDNA Reverse Transcription Kit; Applied
Biosystems, Foster City, CA, USA). Quantitative real-time
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Table 1. Forward and reverse primer sequences used for SYBR qRT-PCR
Target gene and protein Primer sequences Reference
RPS15 F: ATCATTCTGCCCGAGATGGTG Yates et al. (2016)
Ribosomal protein S15 R: TGCTTCACGGGCTTGTAGGTG
Myosin heavy chain 7 (MHY7) F: GAGATGGCCGCGTTTGGGGAG Yates et al. (2016)
MHCI protein R: GGCTCGTGCAGGAAGGTCAGC
MHY2 F: ACCGAAGGAGGGGCGACTCTG Yates et al. (2016)
MHCIIa protein R: GGCTCGTGCAGGTGGGTCATC
MYH1 F: AAAGCGACCGTGCAGAGCAGG Yates et al. (2016)
MHCIIx protein R: GGCTCGTGCAGGTGGGTCATC
Peroxisome proliferator-activated
receptor gamma coactivator 1
alpha (PPARGC1A)
F: GAGATGTGACCACCGAGAATGAG Myers et al. (2008)
PGC1α protein R: GCTGTTGACAAATGCTCTTCGC
Mitofusin 2 (MFN2) F: CATCAGCTATACTGGCTCCAACT This paper
MFN2 protein R: AATGAGCAAAAGTCCCAGACA
Uncoupling protein 2 (UCP2) F: AAGGCCCACCTAATGACAGA This paper
UCP2 protein R: CCCAGGGCAGAGTTCATGT
UCP3 F: GAAAGGAATTCTGCCCAACA Kelly et al. (2011)
UCP3 protein R: TCCAAAGGCAGAGACGAAGT
SLC25A4 F: TGGTGTCCTACCCCTTTGAC Kelly et al. (2011)
Adenine nucleotide translocase 1
(ANT1) protein
R: CAGGCGCCTTTGAAGAAAGC
PCR (qRT-PCR) was performed using a MESA BLUE
Mastermix (Eurogentec, Seraing, Belgium) on a 7500
Fast Real-Time PCR System (Applied Biosystems)
following the recommended protocol for SYBR: an initial
denaturation step (5 min at 95°C) was followed by 40
amplification cycles (15 s at 95°C and 1 min at 60°C).
The primer sequences are given in Table 1. Data were
analysed using the 2−Ct method (Schmittgen & Livak,
2008) and expressed relative to the mRNA levels of the
housekeeper ribosomoal protein S15, and set relative to 1
experimental sample. The product size from each primer
pair was checked by running on an agarose gel.
Immunohistochemistry. Transverse sections (10 μm)
were cut from the fixed frozen samples and transferred
to glass slides for immunostaining (Yates et al. 2016).
Sections were fixed in acetone at −20°C, incubated in
Tris-buffered saline with Triton and Tris-buffered saline
containing 0.1% Tween-20 and 0.1% Triton (TBS-TT)
followed by 3% H2O2 and blocked in TBS containing 5%
goat serum and 2% bovine serum albumin. Primary anti-
body, diluted 1:20 in TBS-TT, was applied overnight at
4°C: MHCI [BA-D5; Developmental Studies Hybridoma
Bank (DSHB), University of Iowa, Iowa City, IA, USA;
RRID: AB 2235587] and MHCII (F18; DSHB; RRID:
AB 528369) and fibres were counterstained with Desmin
(Y66; Abcam, Cambridge, UK; 1:300; RRID: AB 731901).
Alexa Fluor-conjugated secondary antibodies, diluted
1:200, were used to visualise immunocomplexes (Alexa
Fluor 488; Abcam ab150105; RRID: AB 2732856 and
Alexa Fluor 568; Abcam ab175471; RRID: AB 2576207).
AnAxio ImagerA1microscopewasused to takefive images
per section at 40× magnification and ImageJ was used to
quantify the number and average fibre area of type I and
II fibres in the field of view.
Statistical analysis
All results are presented as mean ± SD and analyses
were performed using GraphPad Prism Version 6.05 for
Windows (www.graphpad.com). One-way ANOVA was
applied to the ontogeny data, followed by a Tukey’s
multiple comparison post hoc test as appropriate. A t test or
Mann–Whitney non-parametric test was used to compare
control and TX values at the same age, and to compare
the TX value at 143 dGA to that at 127 dGA. The Pearson
product-moment correlation coefficientwas used to assess
linear correlation between variables and log-transformed
hormone data. Partial correlation analyses were used to
determine the relationship between two variables while




Fetal plasma concentrations of cortisol and T3 showed
a normal prepartum rise towards term (Table 2),
consistent with previous studies (Forhead & Fowden,
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Table 2. Fetal and neonatal hormonal and morphometric measurements and biceps femoris (BF) muscle structural data
104dGA 127dGA 143dGA Newborn




13.8 ± 2.9 aA 12.1 ± 2.9 aA 14.0 ± 6.5 38.2 ± 15.9 aB 25.0 ± 14.4 122.0 ± 59.0 b
Plasma T3 (ng ml−1) 0.33 ± 0.04 aA 0.33 ± 0.03 aA,B 0.21 ± 0.07† 0.60 ± 0.31 aB 0.24 ± 0.04∗ 4.02 ± 0.81 b
Plasma T4 (ng ml−1) 78.0 ± 23.1 104.9 ± 28.6 10.1 ± 5.1‡ 87.8 ± 13.8 13.4 ± 16.1† 83.1 ± 19.0
Morphometry
Body weight (kg) 1.19 ± 0.43 a 2.54 ± 0.25 b 2.33 ± 0.33 3.49 ± 0.63 c 3.25 ± 0.47 3.34 ± 0.34 c
Crown–rump length
(cm)
31.5 ± 2.2 a 41.8 ± 1.9 b 40.0 ± 1.3 45.0 ± 1.3 c 44.0 ± 3.8 49.6 ± 2.4 d
Femur (cm) 5.8 ± 0.9 a 9.3 ± 1.1 b 8.8 ± 0.4 10.3 ± 0.8 b 9.8 ± 1.5 12.8 ± 1.1 c
Tibia (cm) 8.8 ± 0.6 a 12.3 ± 0.8 a,b 11.7 ± 0.5 14.5 ± 1.3 b 13.3 ± 1.3 12.4 ± 5.5 b
Metatarsus (cm) 10.0 ± 0.6 a 14.3 ± 0.6 a,b 13.0 ± 0.6† 16.3 ± 0.8 b,c 14.7 ± 1.0∗ 17.5 ± 0.8 c
BF weight (g) 5.46 ± 0.97 a 11.02 ± 1.12 b 10.92 ± 2.18 13.91 ± 3.30 b,c 13.97 ± 1.90 15.39 ± 2.95 c
BF/body weight ratio
(g kg–1)
4.86 ± 1.10 4.34 ± 0.19 4.71 ± 0.86 3.96 ± 0.38 4.30 ± 0.20∗ 4.61 ± 0.77
Biochemical composition
BF water content (%) 86.8 ± 0.9 a 83.3 ± 1.2 b 85.8 ± 0.9† 79.3 ± 1.4 c 83.5 ± 2.1† 78.6 ± 0.7 c
BF protein content
(mg g–1 wet wt)
44.5 ± 2.9 a 45.7 ± 1.6 a 40.3 ± 5.1∗ 48.3 ± 5.3 a 45.1 ± 4.7 59.6 ± 4.7 b
Data are presented as mean ± SD of fetuses at 104, 127 and 143 days of gestational age (dGA) and newborn lambs. N = 5–6 per
measurement in each group. Values with different letters are significantly different from each other (P < 0.05 by Tukey’s post hoc test
following one-way ANOVA); lower case letters include all four age groups, while upper case letters include 104–143 dGA groups only.
Significantly different from control at the same gestational age: ∗P < 0.05 (by t test); †P < 0.01; ‡P < 0.0001.
2002; Mostyn et al. 2003). Both concentrations rose still
further in the newborn lambs (one-way ANOVA all four
groups; Table 2). Plasma T4 concentration did not differ
significantly with age (Table 2). There were no significant
thyroid gland remnants in TX fetuses at post-mortem
and their plasma concentrations of T3 and T4 were
significantly lower than control values at both gestational
ages (Table 2). TX did not significantly alter fetal plasma
cortisol concentrations at either age (Table 2).
Body weight, CRL, and the lengths of the femur, tibia
and metatarsus increased significantly with age across the
four groups, but only metatarsus length was affected by
TX, being shorter than in the controls at both 127 and
143 dGA (Table 2). BF weight but not BF/body weight
ratio increased significantly with age (Table 2). Muscle
water content decreasedwith agewhile the protein content
increased with age (Table 2). There was no effect of TX on
the BF weight although BF/body weight was greater in
TX than control fetuses at 143 dGA (Table 2). Muscle of
TX fetuses had higher water content than controls, and
protein content was lower in BF of TX than control fetuses
at 127 dGA (Table 2).
Muscle oxygen consumption
The ADP-coupled rates of O2 consumption in the BF are
shown in Fig. 1A for the three respirometry protocols.
Total OXPHOS was significantly higher in neonates than
at any fetal age and was reduced in TX relative to control
fetuses at 127 dGA (Fig. 1A). Pyruvate- and PC-supported
oxidative capacity was also higher in newborns than at 104
and 127 dGA (Fig. 1A). Both pyruvate- and PC-supported
O2 consumption were reduced by TX at 127 and 143 dGA
(Fig. 1A).
Leak state respiration, a measure of O2 use for
processes other than ATP production, differed with age
(Table 3). Using malate and either glutamate or pyruvate
as substrates, leak state O2 consumption increased with
increasing age over the perinatal period, with higher rates
in newborns than in the younger two groups of fetuses
(Table 3). Leak state O2 consumption with malate and PC
was also higher in newborns than at 127 dGA (Table 3).
Leak respiration was not affected by TX at either age using
any substrate (Table 3).
When the data from all the fetal and neonatal groups
were combined, irrespective of age or treatment, there
were significant positive correlations between the three
ADP-coupled rates of O2 consumption and the plasma
concentrations of both cortisol andT3. These relationships
are presented graphically for total OXPHOS in Fig. 2A
and as correlation coefficients for the remaining data in
Table 4. Because the plasma concentrations of cortisol and
T3 are also positively related during the perinatal period
(r = 0.8054, n = 34, P < 0.0001), partial correlation
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society





























































































104dGA 127dGA 143dGA Newborn
104dGA 127dGA 143dGA Newborn
104dGA 127dGA 143dGA Newborn












































































































































































































104dGA 127dGA 143dGA Newborn
104dGA 127dGA 143dGA Newborn
104dGA 127dGA 143dGA Newborn
Figure 1. Functional oxidative capacity of late gestation ovine biceps femoris muscle
Values are mean ± SD. A, ADP-coupled O2 consumption during maximal respiration (malate, glutamate and
succinate-driven; total), respiration supported by pyruvate (Py) plus malate and palmitoyl carnitine (PC) plus malate.
B, citrate synthase (CS) activity and C, O2 consumption normalised to CS activity as labelled. D, β-hydroxyacyl-CoA
dehydrogenase (HOAD) activity. Data are presented for fetuses at 104, 127 (control and TX) and 143 days of
gestational age (dGA; control and TX) and newborn lambs (n = 4–6 per group). Control data are represented by
filled circles and thyroidectomy (TX) data by open circles. Different letters indicate significant difference to each
other (P < 0.05 by Tukey’s post hoc test following one-way ANOVA). Asterisks indicate significantly different from
control at the same gestational age: ∗P < 0.05 (by t test); ∗∗P < 0.01; ∗∗∗P < 0.001.
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Table 3. Leak state respiration
104dGA 127dGA 143dGA Newborn
Control Control TX Control TX Control
Glutamate 1.12 ± 0.59a 0.87 ± 0.28a 0.71 ± 0.48 1.47 ± 1.01a 0.72 ± 0.30
(n = 4)
3.07 ± 1.03b
Pyruvate 0.91 ± 0.64a 1.29 ± 1.32a 0.79 ± 0.36 1.13 ± 0.31a 0.70 ± 0.28
(n = 4)
3.34 ± 1.81b
Palmitoyl carnitine 0.66 ± 0.59a 0.39 ± 0.15a 0.36 ± 0.15 1.36 ± 0.88a,b 0.61 ± 0.28 2.57 ± 1.06
(n = 4)b
Data are presented as mean ± SD leak state respiration (nmolO2 min–1 mg–1 dry weight). N = 5–6 per group unless stated otherwise.
Values with different letters are significantly different from each other (P < 0.05 by Tukey’s post hoc test following one-way ANOVA).
analyses were carried out using the three factors to identify
which hormone concentration had the greater influence
on the rates of muscle O2 consumption. These analyses
showed that T3 was statistically the more dominant factor
for all three rates of O2 consumption as the correlations
withT3 remained significantwhen the variation in cortisol
levels was taken into account, whereas those with cortisol
were not significant in the absence of the confounding
effects of the T3 concentration (Table 4).
Regulating mitochondrial oxidative capacity
Metabolic enzyme activities. CS activity, an enzyme of
the tricarboxylic acid cycle and a putative marker of
mitochondrial density (Larsen et al. 2012), increased
significantly with age with a two-fold higher activity at
143 dGA than at the earlier gestational ages and still
higher values in neonatal muscle (Fig. 1B). At both 127
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Figure 2. Correlation of biceps femoris mitochondrial parameters with circulating cortisol and T3
A, ADP-coupled O2 consumption during respiration supported by maximal respiration (malate, glutamate and
succinate-driven; total), and B, citrate synthase activity plotted against log10 plasma cortisol and T3. Data are
presented for TX fetuses (open symbols) and controls (filled symbols) at 104 (inverted triangles), 127 (circles) and
143 days of gestational age (dGA; squares) and in newborn lambs (triangles). r and P values and n numbers are
given on each graph.
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
J Physiol 598.12 Perinatal development of skeletal muscle mitochondria 2461
Table 4. Correlations, and partial correlation analyses, of plasma hormone concentrations with ADP-coupled respirometry data from




































Log10plasma cortisol (ng ml−1) r = 0.094 r = 0.203 r = 0.011 r = 0.383 r = 0.469
Log10plasma T3 (ng ml−1) r = 0.523 r = 0.588 r = 0.532 r = 0.753 r = 0.516
Significant partial correlations are highlighted in bold (P < 0.05). N = 28–34 for partial correlation analyses.
lower in TX than control fetuses (Fig. 1B). Furthermore,
the normal increase in CS activity between 127 and
143 dGA was prevented by TX (P > 0.05 by t test). To
determine whether the changes in weight-specific muscle
O2 consumption were due to an altered mitochondrial
density or functional capacity per unit of mitochondrial
mass, the ADP-coupled rates of O2 consumption were
normalised to CS activity. There was a trend for decreased
ADP-coupled O2 consumption per mitochondrial unit
with increasing age irrespective of substrate but this only
reached statistical significance with pyruvate and total
OXPHOS (Fig. 1C). There was no significant difference
in O2 consumption per mitochondrial unit in TX fetuses
compared to controls at either age using any substrate
(Fig. 1C).
The capacity for mitochondrial fat metabolism in the
BF was further investigated by measuring the activity of
the β-oxidation enzyme, HOAD. Age had a significant
effect on HOAD activity with higher activity at 143 dGA
and in the newborn than at 104 dGA (Fig. 1D). Thyro-
idectomy reducedHOADactivity relative to control values
at both ages (Fig. 1D) and prevented the normal ontogenic
increase in activity towards term (P > 0.05 by t test).
When the data from all age groups were combined
irrespective of treatment, the activities of CS and HOAD
had a significant positive correlation with the plasma
concentrations of cortisol and T3 (Fig. 2B and Table 4,
respectively). Partial correlation analyses showed that both
hormones have a significant influence on CS and HOAD
activity (Table 4).
Mitochondrial ETS proteins. Age had a significant
influence on protein abundance of ETS complexes I–IV
andATP-synthase. In general, muscle complex abundance
was higher in 143 dGA fetuses and newborns than in
the younger fetal groups with no significant differences
between the 143 dGA and newborn values in most
cases (Fig. 3A). The abundance of several complexes was
significantly lower in TX than control fetuses at both ages
(Fig. 3B). When there were significant increases in BF
complex abundance in controls between 127 and 143dGA,
these did not occur in the TX fetuses (Fig. 3B).
Mitochondrial regulatory genes. The expression of genes
encoding PGC1α and MFN2 were measured as regulators
of mitochondrial biogenesis and fusion, respectively.
MFN2 but not PGC1α expression was influenced by age
(Fig. 4A). Expression of neither gene was affected by TX
(Fig. 4B). Expression of IMM proteins known to dissipate
the proton gradient were also quantified. Both UCP2 and
UCP3 gene expression were upregulated 5- to 7-fold in
the newborn compared with all fetal groups (Fig. 4A) but
were not affected statistically by TX (Fig. 4B). Expression
of the ANT1 gene was significantly higher in newborns
than in all fetus groups (Fig. 4A) and was lower in TX than
control fetuses at 143 dGA (Fig. 4B).
Muscle morphology. Age had a significant positive effect
on both the cross-sectional area (CSA) and proportions
of type I and II fibres in the BF (Fig. 5). In addition,
gene expression of MHCI, IIa and IIx showed a significant
positive effect of age on MHCIIa and MHCIIx (Fig. 6A).
The proportion and CSA of type I fibres were reduced in
BF of TX fetuses relative to controls at 143 dGA (Fig. 5B).
Thyroidectomy reduced expression ofMHCIIx at 127 dGA
andMHCI at 143 dGA relative to control values (Fig. 6B).
In addition, TX prevented the normal ontogenic increase
inMHCIIx seen in the controls between 127 and 143 dGA
(P > 0.05 by t test in all cases).
Discussion
This study demonstrated that, in ovine BF skeletal muscle,
mitochondrial oxidative capacity increased significantly
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society
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with age in a substrate-dependent manner, with the
rate of O2 consumption higher in neonatal than fetal
muscle particularly when using carbohydrates. Over late
gestation there was an increase in mitochondrial density
and abundance of ETS and other proteins involved in
oxidative ATP generation, consistent with other pre-
partum maturational processes known to ensure a
successful transition to extrauterine life (Fowden et al.
1998). Fetal hypothyroidism induced by surgical removal
of the fetal thyroid glands showed that thyroid hormones
are necessary for most of the developmental changes in
mitochondrial function that occur towards term. The BF
from TX fetuses had a significantly lower mitochondrial
density and abundance of proteins involved in oxidative
ATP production near term, as well as delayed maturation
of its muscle fibre composition. Indeed, when the data
from all the animals were combined, there were significant
positive correlations between the oxidative capacity of the
BF and the circulating concentrations of cortisol and T3,
both of which normally act as signals for maturation
and of proximity to delivery. Because cortisol controls
the deiodination of T4 to T3 close to term (Forhead &
Fowden, 2014), the current findings suggest that these
hormones act cooperatively in regulating mitochondrial
function over late gestation, as has been shown previously
for other aspects of prepartummaturation (Forhead et al.
1998, 2002).
Development of mitochondrial oxidative capacity
over the perinatal period
Respiration in the presence of saturating concentrations
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Figure 3. Regulating mitochondrial oxidative capacity in biceps femoris muscle and the impact of thyro-
idectomy
A, representative western blots and mean ± SD protein abundance of electron transfer system complexes I–IV
(CI–IV) and ATP-synthase in biceps femoris (B) over late gestation and in neonatal muscle and (C) in control
(grey bars) and thyroidectomised (TX; open bars) muscle at 127 and 143 dGA. N = 5 in each group. Different
letters indicate significant difference to each other (P < 0.05 by Tukey’s post hoc test following one-way ANOVA).
Asterisks indicate significant difference from control at the same gestational age: ∗P < 0.05 (by t test); ∗∗P < 0.01;
∗∗∗∗P < 0.0001. †Significantly different from control at 127 dGA: P < 0.05 (by t test).
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age-dependent rise in electron transport chain capacity
that was dependent on thyroid hormones. To investigate
the mitochondrial capacity to oxidise more physio-
logical substrates, we measured respiration in the pre-
sence of saturating concentrations of malate plus pyruvate
and, separately, malate plus PC. We found that ovine
fetal skeletal muscle mitochondria have the capacity
to use both carbohydrate-derived (i.e. pyruvate) and
fatty acid-derived (i.e. PC) substrates for oxidative
metabolism throughout the last third of gestation. In
normal conditions, in vivo studies of the whole sheep
fetus show that carbohydrate in the form of glucose is
its predominant metabolic substrate although free fatty
acids are available in the fetal circulation during late
gestation and rise rapidly in concentration postnatally
(James et al. 1971; Mellor & Cockburn, 1986). Seemingly,
in line with these findings, the current results show that
rates of O2 consumption using pyruvate were around 2–3
timeshigher than those seenwithPCbut, inmitochondrial
preparations in vitro, pyruvate typically supports higher
respiration rates than fatty acid-derived substrates, due
to more rapid production of reducing intermediates.
Notably, there was a perinatal increase in muscle activity
of the fatty acid β-oxidation enzyme, HOAD, in the
current study, which indicates that fat may become a
more prominent metabolic substrate postnatally with the
onset of a milk diet with its high fat content (Herrara &
Amusquivar, 2000).
Themajor increase inmuscleO2 consumptionoccurred
neonatally with little, if any, change during late gestation,
consistent with previous findings of a 58% increase in
the whole body rate of O2 consumption in the newborn
lamb (Smolich et al. 1992). However, mitochondrial
density, as measured by CS activity, and the abundance
of ETS proteins increased in late gestation in advance
of delivery. As there was no significant change in gene
expression of PGC1α before birth, PGC1α is unlikely to
be amajor regulatory factor ofmitochondrial density over
late gestation. The increased mitochondrial density may
relate to the increased proportion of type I fibres that
have moremitochondria over this period of development.
There was also an increase in MFN2 expression post-
natally compared with 145 dGA, indicating increased
mitochondrial fusion, which, in turn, is associated with
enhanced ATP production when energy demands are high
(Schrepfer & Scorrano, 2016). The positive correlations
observed between the cortisol concentration and the
activities of CS and HOAD, as well as with the rates of
O2 consumption, suggest that prepartum maturation of
mitochondrial oxidative capacity may be dependent on
cortisol, as occurs with other metabolic processes towards
term (Fowden et al. 1998). Collectively, our findings
show that there is prepartum upregulation of capacity for
mitochondrial oxidative phosphorylation in anticipation
of the increased neonatal ATP requirement.
The temporal discrepancy between the increments in
mitochondrial density and total OXPHOS capacity is
a novel finding and indicates that different regulatory
mechanisms may drive prenatal maturation and neonatal
upregulation of mitochondrial oxidative function in
skeletal muscle. In vivo, neonatal upregulation of
mitochondrial O2 consumption capacity may be due to
either removal of an inhibitory feto-placental factor or
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Figure 4. Regulating mitochondrial oxidative capacity in biceps femoris muscle and the impact of thyro-
idectomy
Values are mean ± SD mRNA levels of peroxisome proliferator-activated receptor gamma coactivator 1 alpha
(PGC1α), mitofusin 2 (MFN2), uncoupling proteins (UCP) 2 and 3, and adenine nucleotide translocase 1 (ANT1):
A, over late gestation and in neonatal muscle; and B, in control (grey bars) and thyroidectomised (TX; open bars)
muscle at 127 and 143 dGA. N = 5–6 in each group. Different letters indicate significant difference to each other
(P < 0.05 by Tukey’s post hoc test following one-way ANOVA). ∗Significantly different from control at the same
gestational age (P < 0.05 by t test).
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extra-uterine environment, for example due to alterations
in the electrolyte, O2 and substrate availability (Ogbi &
Johnson, 2006; Huttemann et al. 2007; Solaini et al. 2010).
In the current in vitro experimental setting, however, these
factors are controlled and, thus, altered expression of
mitochondrial factors, such as the observed upregulation
of ANT1, may play a crucial regulatory role in the
postnatal increase in OXPHOS and O2 consumption by
maintaining ADP levels in the mitochondrial matrix to
support ATP-synthase activity. The delay in upregulating
mitochondrial respiratory capacity until after delivery,
despite the prepartum increase in mitochondrial density,
may be beneficial in restricting fetal O2 demand in utero
when the O2 supply is limited.
The marked neonatal increase in UCP and ANT1
expression will also contribute to minimising superoxide
production by dissipating the proton gradient across the
IMM (Arsenijevic et al. 2000; Vidal-Puig et al. 2000;
Brand et al. 2005), in line with the ontogenic increase
in leak state respiration observed perinatally in the
current study. Although proton leak is thought to reduce
the efficiency of oxidative phosphorylation, concomitant
increases in ATP synthesis and UCP expression have been
reported previously in rats, suggesting that uncoupling
may have a negligible effect on ATP availability when
oxidative phosphorylation is working at maximal rates
(Vidal-Puig et al. 2000; Short et al. 2001). Muscle UCP3
may also be involved in upregulating lipid metabolism
after birth (Clapham et al. 2000). In addition, the 2- to
3-fold increment in ANT1 abundance after birth may
increase both mitochondrial availability of ADP required
for OXPHOS and the cellular availability of ATP, by
enhancing transport of ADP into, and ATP out of, the
inner mitochondrial space (Brand et al. 2005).
Developmental effects of fetal hypothyroidism
As in postnatal tissue (Lombardi et al. 2015), the
current study shows that thyroid hormones are important
metabolic regulators in fetal skeletal muscle. In late
gestation, O2 consumption by TXmuscles was lower than
control values in a substrate-specific manner, consistent
with the low whole body rates of O2 consumption in TX
sheep fetuses (Fowden & Silver, 1995). The lower rates
of muscle O2 consumption after TX were accompanied
by reductions in CS activity and the abundance of ETS
complexes and ATP-synthase. These decrements were
more pronounced at 143 than at 127 dGA. TXmuscles also
had lower HOAD activity and expression of ANT1 than
control muscles by 143 dGA. In addition, TX abolished
the developmental increase in mitochondrial oxidative





















































































































Control ControlControl TX Control TX
104dGA 127dGA 143dGA Newborn
104dGA 127dGA 143dGA Newborn
104dGA 127dGA 143dGA Newborn
Figure 5. Maturation of late gestation and neonatal biceps femoris muscle structure and the impact of
thyroidectomy
A and B, immunostaining of type I (A) and type II (B) fibres; representative 10 μm cross sections stained for myosin
heavy chain isoforms I and II (green) and counterstained for desmin (red) at 104 and 143 days of gestational age
(dGA) as labelled. Muscle sections from sham and thyroidectomised (TX) fetuses are shown at 143 dGA. White
scale bar = 100 μm. C and D, mean ± SD cross sectional area (CSA) of type I (C) and type II (D) fibres. Control
data are shown in grey and thyroidectomy (TX) data in open bars. E, mean ± SD proportion of type I (red), type
II (green) and undefined (white) fibres of fetuses at 104, 127 (control and TX) and 143 dGA (control and TX) and
newborn lambs. N = 5–6 in each group. Different letters indicate significant difference to each other (P < 0.05
by Tukey’s post hoc test following one-way ANOVA). Asterisks indicate significant difference from control at the
same gestational age: ∗P < 0.05 (by t test); ∗∗P < 0.01.
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Furthermore, TX was associated with a lower proportion
of type I fibres and more undifferentiated muscle fibres in
the BF at 143 dGA, in line with previous studies of other
skeletal muscles in fetal sheep (Finkelstein et al. 1991).
Together, the current findings suggest that the effects of
thyroid hormones on muscle mitochondrial function in
utero may be mediated at least, in part, by their role in
muscle fibre differentiation.
Thyroid hormones may act directly to influence fetal
muscle fibre type and mitochondrial function as their
receptors are known to be expressed in fetal skeletalmuscle
during late gestation (Duchamp et al. 1994). The rise in
the proportion of type II fibres between 105 and 127 dGA,
despite no alteration in cortisol or T3 concentrations,
suggests that changes in the abundance of their hormone
receptors or the tissue deiodinases may contribute to
the normal developmental changes in skeletal muscle, as
occurs in other fetal tissues over this period of gestation
(Polk et al. 1989; Mostyn et al. 2004; Wu et al. 2005).
Alternatively, the actions of thyroid hormones may be
indirect and mediated through other hormones or fetal
tissues, which then affect muscle development. Previous
studies in fetal sheep have shown that thyroid hormone
deficiency affects bioavailability of insulin and insulin-like
growth factors, both of which are known to affect
muscle development in utero (Forhead et al. 2002; Harris
et al. 2017). Fetal hypothyroidism also impairs normal
cerebral development, which in turnmay reduce neuronal
stimulation of skeletal muscle with known developmental
effects on the proportion of different fibre types in rats
(Gambke et al. 1983; Horn & Heuer, 2010). Whatever
the mechanism involved in utero, the positive correlations
observed between the fetal T3 concentrations and both
muscle O2 consumption and mitochondrial density show
that fetal thyroid hormones have an important role
in controlling mitochondrial oxidative capacity during
the immediate prepartum period, consistent with the
role of these hormones in increasing metabolic rate
in the adult (Harper & Seifert, 2008). Indeed, partial
correlation analyses suggest T3 is the dominant factor
driving development of mitochondrial function, albeit
this may be a T3-mediated, cortisol-dependent process
(Forhead & Fowden, 2014). However, further studies
are needed using adrenalectomised fetuses and T4/T3
replacement in TX fetuses to establish the precise nature
of this endocrine interdependence.
Conclusion
Collectively, the results show that the capacity of skeletal
muscle for ATP production increases in utero in advance
of the extra energy requirement at birth by increasing the
number of mitochondria and their functional capacity
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Figure 6. Maturation of fetal and neonatal skeletal muscle structure and the impact of thyroidectomy
Mean ± SD gene expression of MHCI, MHCIIa and MHCIIx in fetuses at 104, 127 and 143 days of gestational
age (dGA) and newborn lambs (A) and 127 dGA and 143 dGA sham (grey) and thyroidectomised (TX; open bars)
fetuses (B) in biceps femoris. N = 4–6 per group. Values with different letters are significantly different from each
other (P < 0.05 by Tukey’s post hoc test following one-way ANOVA). Asterisks indicate significant difference from
control at the same gestational age: ∗P < 0.05 (by t test); ∗∗P < 0.01). †Significantly different from control at
127 dGA: P < 0.05 (by t test).
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evidence for any increase in the rate of O2 consumption
per se until after delivery. Coupled with the decline
in oxidative capacity per mitochondrial unit, this may
be a mechanism to more effectively control superoxide
production and oxidative stress during the transition
from intra- to extra-uterine life. The thyroid hormones
appear to influence mitochondrial oxidative capacity via
effects on myogenesis and differentiation of the muscle
fibres while other factors, such as the fetal cortisol
concentration, enhancemitochondrial biogenesis andETS
complex abundance in differentiated fibres close to term.
However, further studies are required to identify the
specific molecular mechanisms and signalling pathways
involved in the prepartum maturation and neonatal
upregulationofmitochondrialOXPHOS.Agreater under-
standing of these regulatory processes and their end-
ocrine dependence in utero is likely to have beneficial
consequences for the viability and long-term metabolic
health of infants born pre-term or with prenatal thyroid
hormone deficiency.
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